CN Patent

CN103547266A — 药物组合物

Assigned to ViiV Healthcare Co · Expires 2014-01-29 · 12y expired

What this patent protects

本发明涉及(3S,11aR)-N-[(2,4-二氟苯基)甲基]-2,3,5,7,11,11a-六氢-6-羟基-3-甲基-5,7-二氧代-噁唑并[3,2-a]吡啶并[1,2-d]吡嗪-8-甲酰胺的药物组合物，其用于治疗或防止人类免疫缺陷性病毒(HIV)感染。

USPTO Abstract

本发明涉及(3S,11aR)-N-[(2,4-二氟苯基)甲基]-2,3,5,7,11,11a-六氢-6-羟基-3-甲基-5,7-二氧代-噁唑并[3,2-a]吡啶并[1,2-d]吡嗪-8-甲酰胺的药物组合物，其用于治疗或防止人类免疫缺陷性病毒(HIV)感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN103547266A
Jurisdiction
CN
Classification
—
Expires
2014-01-29
Drug substance claim
No
Drug product claim
No
Assignee
ViiV Healthcare Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.